Fundraising FoxDigital Health Startups
8,094 companies tagged Digital Health, with their investors and founders.
PillPack is a full-service pharmacy that organizes and delivers medications to customers, managing automatic refills and coordinating directly with doctors and insurance providers.
14 investors
SpruceID provides digital identity systems for governments and regulated industries, enabling secure verification and authentication across legacy and modern infrastructure. The company specializes in integrating identity solutions with existing workflows, using open standards to ensure interoperability and long-term flexibility.
14 investors
Twentyeight Health is a telehealth service that lets users complete an online medical questionnaire reviewed by a licensed provider, who writes prescriptions for sexual and reproductive health needs and mails medication directly to patients. It offers a subscription plan with provider messaging, free shipping, and access to over-the-counter products, with a focus on making women's healthcare more accessible.
14 investors
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.
14 investors
Assort provides voice AI agents for healthcare that use deep patient interaction data to proactively guide patients through their care journey, orchestrating tasks from intake and scheduling to billing and care gap closure.
13 investors
Big Health develops digital treatments and care programs for mental health conditions, including cognitive behavioral therapy-based solutions for insomnia and other mental health issues. The company serves patients and healthcare systems seeking scalable, accessible mental health care backed by clinical research.
13 investors
Brave Health is a virtual mental healthcare provider offering telehealth therapy delivered by licensed providers across a growing number of U.S. states. It serves patients on Medicaid, Medicare, and over 200 commercial insurance plans.
13 investors
Centivo is a primary-care-centered health plan administrator for self-funded employers, sold through benefits brokers and consultants. It serves mid-market and large U.S. employers (50+ employees), using a model of free primary care, no deductibles, and low copays to lower healthcare costs.
13 investors
Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites. The platform emphasizes modern technology, data integrity, and compliance for advancing medical research.
13 investors
Everlywell offers at-home lab testing kits and virtual healthcare services across multiple wellness categories including daily health screening, digestive analysis, sexual health testing, and hormone monitoring.
13 investors
Hey Jane is a US virtual clinic that connects patients with clinicians via telehealth for abortion care and other reproductive and sexual health services. It serves patients across 24 states, offering evidence-based care with insurance or financial aid options.
13 investors
Hippocratic AI develops generative AI agents designed for healthcare delivery, working with hospital systems, health plans, and life sciences companies to support clinical decision-making and patient care. The company combines AI technology with healthcare expertise to deploy AI solutions across provider, payer, and pharmaceutical segments.
13 investors
Lyra provides mental health care services through a network of evidence-based providers, combining clinical expertise with technology to deliver accessible, quality care for employers and health plans.
13 investors
Siren develops technology for early detection of diabetic foot ulcers to reduce injury risk. The company serves healthcare providers and patients managing diabetes.
13 investors
SonderMind connects clients with therapists and psychiatry providers, offering virtual and in-person mental health care that accepts most major insurance plans, Medicare, Medicare Advantage, TriCare, and self-pay. It uses a measurement-based care approach and operates across all 50 U.S. states.
13 investors
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.
13 investors
SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.
13 investors
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.
12 investors
Atropos Health develops a cloud-based platform that generates real-world evidence from electronic health records to inform clinical decision-making and healthcare research. The company enables healthcare institutions, clinicians, and life sciences organizations to rapidly conduct observational studies from patient data for personalized medicine and evidence-based practice.
12 investors
Unable to determine company information; page contains only placeholder Lorem ipsum text.
12 investors
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
12 investors
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening. The test offers an alternative to low-dose CT imaging for patients meeting USPSTF criteria and is made available to health systems, primary care providers, and lung screening programs.
12 investors
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds. Its pipeline includes a Phase 2-ready asset and multiple preclinical programs targeting brain health and neuroplasticity.
12 investors
Ellipsis Health builds Sage, an AI voice agent designed to support healthcare organizations by handling patient interactions and expanding clinical capacity. The platform aims to improve patient care coordination across physical, mental, and social needs while freeing clinicians to focus on complex care.
12 investors